Migraine for Pain Physicians: Clinical Diagnosis, Red Flags, Differential Diagnosis, and Practical Management

Migraine is a common, disabling, and clinically heterogeneous primary headache disorder of major relevance to pain physicians. Although often perceived as a neurological condition managed mainly in general practice or neurology clinics, migraine frequently presents in pain practice because of its overlap with cervical pain, myofascial pain syndromes, occipital pain, temporomandibular disorders, facial pain, sleep disturbance, medication overuse, and chronic pain sensitization. In such settings, a pain physician must not only identify migraine accurately but also distinguish it from secondary headache disorders and from overlapping regional pain syndromes that may coexist.

From a practical standpoint, migraine is important because it is often underdiagnosed, misclassified, or incompletely treated. Many patients presenting to pain clinics have already received repeated symptomatic treatment, unnecessary imaging, or procedure-oriented management without a structured headache diagnosis. Therefore, a physician-level understanding of migraine is essential for rational management, avoidance of diagnostic error, and appropriate patient selection for medical and interventional strategies.

Definition and Clinical Relevance

Migraine is a recurrent primary headache disorder characterized by attacks of moderate to severe headache lasting 4 to 72 hours, commonly associated with nausea, vomiting, photophobia, phonophobia, and aggravation by routine physical activity. In a proportion of patients, migraine is preceded or accompanied by aura, consisting of transient reversible focal neurological symptoms, most commonly visual.

While classic descriptions emphasize unilateral, pulsatile headache, real-world migraine is often more variable. The pain may be bilateral, pressing, occipital, peri-orbital, facial, or associated predominantly with cervical discomfort. Therefore, the diagnosis of migraine should not be restricted to textbook descriptions of one-sided throbbing pain. In many cases, the associated features, recurrence pattern, disability profile, and trigger relationship are more diagnostically useful than pain location alone.

For pain physicians, migraine must be viewed not as an isolated headache complaint, but as a disorder situated at the intersection of headache medicine, sensory sensitization, chronic pain biology, and musculoskeletal overlap.

Pathophysiological Basis of Migraine

Migraine is a neurobiological disorder rather than a purely vascular headache syndrome. Its pathophysiology is complex and involves abnormal sensory processing, trigeminovascular activation, neuropeptide release, altered brainstem modulation, hypothalamic involvement, cortical excitability changes, and peripheral as well as central sensitization.

Activation of the trigeminovascular system plays a key role in migraine pain generation. Nociceptive afferents innervating intracranial vessels and meninges transmit signals centrally, contributing to headache and associated sensory hypersensitivity. Calcitonin gene-related peptide and related mediators are important in this cascade and have become central therapeutic targets in modern migraine management.

In migraine with aura, cortical spreading depolarization is considered a major neurophysiological substrate. This wave of neuronal and glial depolarization propagates across the cortex and correlates clinically with the gradual evolution of reversible aura symptoms.

Sensitization mechanisms are particularly relevant in pain practice. Repeated migraine activity may produce peripheral and central sensitization, resulting in cutaneous allodynia, worsening frequency, neck and scalp tenderness, lower pain thresholds, and transformation toward chronic migraine. This partly explains why migraine patients presenting to pain clinics often demonstrate overlapping myofascial tenderness and amplified pain responses.

Classification of Migraine Relevant to Pain Practice

Migraine may be classified clinically into several subtypes, of which the following are particularly relevant to pain physicians.

Migraine Without Aura

This is the most common subtype. It is characterized by recurrent headache attacks with typical migraine-associated symptoms but without preceding focal neurological aura. In practice, this is the subtype most frequently misdiagnosed as sinus headache, cervical headache, or nonspecific recurrent headache.

Migraine With Aura

This subtype includes reversible focal neurological symptoms that usually develop gradually and are followed by headache. Visual aura is most common, but sensory and language symptoms may occur. Correct recognition is essential because aura may be confused with transient ischemic phenomena, especially in older patients or in those presenting for the first time.

Chronic Migraine

Chronic migraine is defined by headache occurring on 15 or more days per month for more than 3 months, with migraine features present on at least 8 days per month. This is one of the most important migraine phenotypes encountered in pain practice because such patients frequently have medication overuse, cervical myofascial pain, sleep disturbance, mood symptoms, and marked functional impairment.

Menstrual Migraine

This pattern is clinically important because attacks may be more severe, prolonged, and less responsive to routine acute therapy. A careful headache calendar is useful in identifying hormonal periodicity.

Vestibular Migraine

Some patients present primarily with recurrent vertigo, dizziness, imbalance, or motion sensitivity, with headache either absent or not dominant in every episode. Pain physicians should remain aware of this phenotype when evaluating complex recurrent head and neck symptom clusters.

Hemiplegic Migraine and Migraine With Brainstem Symptoms

These less common forms are diagnostically significant because they overlap with serious neurological differentials. They demand careful clinical evaluation and often multidisciplinary involvement.

Clinical Phases of a Migraine Attack

Migraine attacks often progress through distinct phases, although not all phases are present in all patients.

Prodromal Phase

The prodrome may occur several hours to one or two days before the headache. Symptoms may include fatigue, yawning, food craving, irritability, reduced concentration, mood change, neck discomfort, and altered energy level. In many patients, these features are retrospectively recognized only after careful questioning.

Aura Phase

Aura typically develops gradually over 5 to 20 minutes and usually lasts less than 60 minutes. Visual aura is the most frequent presentation and may consist of flashing lights, zigzag lines, scintillating scotoma, shimmering phenomena, or expanding visual disturbance. Sensory aura may include unilateral tingling or numbness spreading gradually over a limb or face. Dysphasic symptoms may also occur.

The gradual progression and full reversibility of aura are important clinical clues.

Headache Phase

The headache phase usually lasts 4 to 72 hours. The pain may be unilateral or bilateral, pulsatile or pressure-like, and is typically moderate to severe in intensity. Associated symptoms include nausea, vomiting, photophobia, phonophobia, osmophobia, and worsening with physical activity. In sensitized patients, scalp tenderness and allodynia may be prominent.

Postdromal Phase

Following headache resolution, patients may experience fatigue, mental dullness, residual heaviness, neck discomfort, and reduced functional capacity. This post-attack phase is important because patients may continue to feel unwell despite apparent headache cessation.

Clinical Diagnosis of Migraine

Migraine is primarily a clinical diagnosis. In most cases, diagnosis depends more on a well-structured history than on imaging or laboratory testing. The physician should obtain a clear account of attack pattern, duration, associated symptoms, aura phenomena, trigger relationship, functional impairment, medication use, and evolution over time.

Important points in clinical history include:

• age at onset
• temporal profile of attacks
• headache frequency
• duration of untreated attacks
• location and quality of pain
• severity and disability
• associated nausea, photophobia, phonophobia, or vomiting
• presence and characteristics of aura
• menstrual relationship
• sleep pattern
• use of acute medications
• family history of migraine
• progression toward increasing frequency
• history suggestive of medication overuse
• coexisting cervical pain, facial pain, TMJ dysfunction, or myofascial pain

A headache diary should be strongly encouraged, especially in patients with frequent headache, uncertain triggers, chronic migraine, or suspected medication overuse.

Clinical Features Supporting the Diagnosis of Migraine

A diagnosis of migraine becomes more likely when recurrent headache episodes are associated with:

• nausea or vomiting
• photophobia and phonophobia
• aggravation by physical activity
• moderate to severe disability
• episodic recurrence with similar phenotype
• identifiable trigger pattern
• family history of migraine
• sensory sensitivity
• aura with gradual onset and reversibility

In clinical practice, the combination of recurrent disabling headache and associated sensory symptoms is often more useful than the isolated feature of throbbing pain.

Migraine Aura: Diagnostic Importance and Clinical Nuance

Migraine aura deserves particular attention in physician-level teaching because it is commonly misunderstood. Typical aura symptoms evolve gradually rather than suddenly, often spread over several minutes, and resolve fully. Visual phenomena are usually positive rather than negative, such as flashing or shimmering patterns rather than simple blackout alone.

This temporal evolution helps differentiate aura from many vascular events, which often begin abruptly and reach maximum intensity immediately. However, first-time aura, late-life onset aura, atypical prolonged aura, isolated motor symptoms, or monocular visual loss should always be approached cautiously.

Pain physicians should be especially careful not to label all transient neurological symptoms as migraine aura without considering stroke, transient ischemic attack, seizure-related events, retinal pathology, or structural neurological disease.

Red Flags Suggesting Secondary Headache

Although migraine is common, secondary headache disorders must be actively excluded whenever warning signs are present. A physician assessing headache should always screen for red flags.

Important red flags include:

• sudden thunderclap headache
• first or worst headache of life
• new onset headache after age 50
• progressively worsening headache pattern
• headache with fever or meningism
• headache associated with cancer or immunosuppression
• focal neurological deficit not typical of aura
• persistent altered consciousness
• seizures
• papilledema
• headache triggered by exertion, cough, or Valsalva
• headache in pregnancy or postpartum period
• new headache after trauma
• persistent side-locked headache with atypical features
• significant recent change in an established headache pattern

The presence of red flags should prompt appropriate investigation rather than reflex labeling as primary migraine.

Differential Diagnosis in Pain Practice

Migraine frequently overlaps with conditions commonly encountered by pain physicians, and careful differentiation is necessary.

Tension-Type Headache

Tension-type headache is generally milder, less disabling, and less likely to be associated with nausea or prominent sensory hypersensitivity. However, overlap can occur, especially in chronic headache sufferers.

Cervicogenic Headache

This diagnosis should be considered when headache appears to arise from cervical structures and is related to neck movement, posture, or reduced cervical range of motion. Nevertheless, neck pain is common in migraine, and the presence of cervical discomfort alone does not establish cervicogenic headache.

Occipital Neuralgia

Occipital neuralgia is typically characterized by paroxysmal shooting or stabbing pain in the occipital nerve distribution, often with focal tenderness. Continuous headache with nausea, photophobia, or recurrent prolonged attacks suggests migraine or mixed headache phenotype rather than pure neuralgia.

Trigeminal Autonomic Cephalalgias

Cluster headache and related trigeminal autonomic cephalalgias present with short-lasting, severe unilateral headaches associated with marked cranial autonomic features such as lacrimation, conjunctival injection, nasal congestion, or ptosis. These conditions differ in duration, attack clustering, and behavioral pattern from migraine.

Temporomandibular Disorder

Temporal and facial pain due to TMJ dysfunction may overlap with migraine. Joint tenderness, crepitus, and pain aggravated by chewing favor TMJ disorder, whereas recurrent disabling headache with sensory hypersensitivity favors migraine.

Sinus Headache

A large number of patients diagnosed with sinus headache actually have migraine. True sinus-related headache should be supported by symptoms suggesting acute rhinosinusitis rather than facial pressure alone.

Secondary Intracranial Disorders

Intracranial mass lesions, idiopathic intracranial hypertension, spontaneous intracranial hypotension, vascular disorders, infections, and inflammatory conditions must be considered when the clinical picture is atypical or red flags are present.

Examination in a Patient With Suspected Migraine

Neurological examination is often normal between attacks in patients with primary migraine. Nevertheless, careful examination remains essential to exclude secondary causes and identify overlapping pain generators.

The physician should assess:

• general systemic condition and vital signs
• cranial nerve function
• focal motor or sensory deficits
• cerebellar signs
• fundus if feasible
• cervical range of motion
• cervical facet loading and segmental tenderness
• occipital nerve tenderness
• temporomandibular joint function
• scalp or facial allodynia
• trigger points in cervical and pericranial musculature

The examination may help identify associated cervical or myofascial pathology, but it should not replace a history-driven diagnosis of migraine.

Role of Neuroimaging

Routine neuroimaging is not necessary in every patient with a typical migraine history and a normal examination. Unnecessary imaging may create cost burden, incidental findings, and patient anxiety without improving care.

Imaging is more appropriate when:

• red flags are present
• neurological examination is abnormal
• headache pattern has changed significantly
• onset is unusually late
• headache is sudden or explosive
• side-locked headache is persistent and atypical
• systemic disease raises suspicion of secondary pathology

The decision to investigate should be guided by clinical suspicion rather than routine habit.

Acute Management of Migraine

The aim of acute migraine treatment is rapid restoration of function, relief of pain, control of associated symptoms, and prevention of recurrence. Therapy should ideally be matched to attack severity and administered early in the course of the attack.

Non-Specific Acute Therapies

For mild to moderate attacks, simple analgesics and nonsteroidal anti-inflammatory drugs may be effective. Antiemetics are useful when nausea is present and may also enhance absorption of oral medication.

Migraine-Specific Acute Therapies

Triptans are a major class of migraine-specific acute agents and are generally indicated in moderate to severe attacks or when simpler therapy fails. Their success depends greatly on patient selection, timing of administration, and avoidance of overuse.

Newer migraine-specific therapies may also be considered depending on availability and patient suitability, especially in those with contraindications to conventional agents.

Practical Considerations

Patients should be educated to:

• treat early rather than after severe escalation
• avoid frequent repetition of acute medication
• understand monthly usage limits
• maintain a headache diary to assess true response

Acute treatment failure is often due to delayed dosing, under-treatment of nausea, poor attack stratification, or medication overuse rather than true refractoriness alone.

Medication Overuse Headache

Medication overuse headache is highly relevant in pain clinics. Patients with frequent migraine often begin taking analgesics, combination painkillers, or migraine-specific medications too frequently, leading to escalation of headache burden and reduced responsiveness to treatment.

Clinical clues include:

• headache on most days
• increasing need for rescue medication
• short-lived relief followed by recurrence
• morning headache
• chronic daily or near-daily headache pattern

Management requires identification of the overuse pattern, patient counseling, withdrawal or reduction of the offending medication when feasible, and simultaneous introduction or optimization of preventive therapy. Failure to address medication overuse is a common reason for poor outcomes in chronic migraine.

Preventive Treatment of Migraine

Preventive therapy is indicated when migraine is frequent, disabling, prolonged, refractory to acute treatment, associated with medication overuse, or when chronic migraine is present. The goal is not only reduction in attack frequency, but also reduction in severity, improved response to acute medication, and restoration of quality of life.

Oral Preventive Agents

Several medication classes are used for migraine prevention, including:

• beta blockers
• selected antidepressants
• anticonvulsants
• selected calcium channel blockers in appropriate settings

Choice of agent should depend on the patient’s comorbidities, age, sleep pattern, mood symptoms, body habitus, cardiovascular status, and tolerability considerations.

CGRP-Targeted Preventive Therapies

Therapies directed against calcitonin gene-related peptide pathways represent an important development in migraine prophylaxis and are particularly useful in patients with frequent episodic migraine or chronic migraine who do not respond adequately to conventional options.

OnabotulinumtoxinA

OnabotulinumtoxinA has an important role in chronic migraine management and is of particular relevance to pain physicians. It is best considered in patients with high-frequency or chronic migraine, especially when oral preventive options have failed, are contraindicated, or poorly tolerated.

Interventional Relevance in Pain Practice

Pain physicians often see migraine patients because of associated cervical pain, scalp tenderness, occipital pain, or refractory chronic headache. Interventional strategies may have a role, but they should always be based on clear phenotype assessment rather than symptom location alone.

Greater Occipital Nerve Block

This may be useful in selected migraine patients, particularly those with prominent occipital tenderness, transitional treatment needs, or acute exacerbation states.

Trigger Point Injections

These may benefit patients in whom cervical or pericranial myofascial pain is clearly contributing to the overall headache burden.

OnabotulinumtoxinA

This remains one of the most evidence-supported interventional approaches for chronic migraine.

Important Caution

Not every migraine with neck pain is cervicogenic headache. Not every occipital headache warrants repeated nerve blocks. Over-proceduralization without phenotype clarity may delay appropriate preventive therapy and reinforce passive pain behaviors.

Chronic Migraine and the Pain Physician

Chronic migraine deserves particular emphasis because this is the phenotype most commonly referred to pain specialists. These patients often exhibit multiple interacting problems:

• central sensitization
• scalp and cervical allodynia
• myofascial pain overlap
• sleep disturbance
• mood disorder
• medication overuse
• functional impairment
• fear of activity
• reduced quality of life

Management should be multimodal and longitudinal rather than episodic. Effective care usually requires a combination of:

• diagnostic clarification
• medication-overuse correction
• preventive pharmacotherapy
• selected procedural intervention
• sleep and lifestyle stabilization
• behavioral support
• close follow-up using headache frequency metrics

In such patients, improvement is often gradual. It is important to frame success in terms of reduction in monthly headache days, reduced disability, better acute treatment response, and improved function.

Migraine and Neck Pain: A Teaching Pearl

One of the most important clinical misconceptions in pain practice is the assumption that significant neck pain excludes migraine. In reality, neck pain is common in migraine and may occur in the prodromal, headache, or postdromal phases. It may reflect central sensitization, trigeminocervical convergence, or associated muscular guarding.

Therefore, the presence of neck pain should broaden the examination, not narrow the diagnosis prematurely to cervicogenic headache.

Non-Pharmacological Measures

Migraine care should include structured non-pharmacological management. These measures are not merely supportive; they are often fundamental to improving stability in recurrent migraine.

Important measures include:

• regular sleep schedule
• consistent meal timing
• hydration
• moderated caffeine intake
• graded physical activity
• trigger awareness without excessive restriction
• stress reduction
• management of insomnia and anxiety
• use of headache diaries

These measures are especially valuable in chronic migraine and in patients with overlapping chronic pain syndromes.

Common Errors in Clinical Practice

Pain physicians should avoid several common pitfalls:

• diagnosing sinus headache without adequate evidence
• attributing all neck-associated headache to cervical origin
• performing repeated procedures before establishing headache phenotype
• ignoring medication overuse
• delaying preventive therapy in frequent migraine
• ordering routine imaging in typical migraine without indication
• failing to investigate red flags
• misinterpreting atypical neurological symptoms as benign aura without caution

Avoidance of these errors substantially improves diagnostic accuracy and treatment outcomes.

Key Clinical Messages for Pain Physicians

Migraine is a major disorder within the scope of pain practice and should be approached with the same diagnostic rigor applied to other chronic pain syndromes. A history-based diagnosis remains central. Associated symptoms, recurrence pattern, disability profile, and response pattern are often more informative than site of pain alone. Pain physicians must remain alert to secondary headache red flags, medication overuse, chronic migraine transformation, and overlap with cervical and myofascial pain syndromes.

When managed systematically, migraine outcomes can improve significantly. The most effective care arises from correct diagnosis, rational acute therapy, timely preventive treatment, selected procedural intervention in appropriate cases, and longitudinal follow-up grounded in function and headache frequency.

FAQ

Is migraine always throbbing and unilateral?

No. Migraine may be bilateral, pressure-like, occipital, facial, or associated predominantly with neck discomfort. The associated symptoms and recurrent attack pattern are often more useful diagnostically.

Can migraine be associated with neck pain?

Yes. Neck pain is common in migraine and does not automatically indicate cervicogenic headache.

Does every patient with migraine require brain imaging?

No. Imaging is not routinely required in patients with a typical migraine history and normal neurological examination. It is indicated when red flags or atypical features are present.

Why is medication overuse important in pain practice?

Because many patients with frequent headache self-escalate analgesic use, resulting in worsening headache frequency and poor treatment response. Unless medication overuse is recognized, long-term control may remain poor.

What is the specific role of the pain physician in migraine care?

The pain physician plays an important role in diagnostic clarification, differentiation from overlapping head and neck pain syndromes, recognition of chronic migraine, management of medication overuse, use of onabotulinumtoxinA where appropriate, and selection of targeted interventional strategies in properly chosen patients.

GET PPT